UGNE Insider Trading
UGNE | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at UGNE provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2012-01-06 03:32 | 2011-12-21 | Odlaug Theron Edwin | Director | BUY | $0.53 | 10,000 | $5,300 | 10,000 | +100.0% |
| 2011-12-23 00:50 | 2011-12-21 | Shields Paul | Officer - Vice Pres. Mfg. Operations | BUY | $0.53 | 2,000 | $1,050 | 13,100 | +18.0% |
| 2011-12-23 00:49 | 2011-12-21 | Palmer Ashleigh | Director, Officer - President & CEO | BUY | $0.53 | 10,000 | $5,288 | 60,000 | +20.0% |
| 2011-12-23 00:49 | 2011-12-21 | Tavakkol Roxanne | Officer - VP, Global Regulatory Affairs | BUY | $0.64 | 1,500 | $953 | 1,500 | +100.0% |
| 2011-12-23 00:48 | 2011-12-21 | Thomas Jenene D. | Officer - VP of Investor Relations | BUY | $0.53 | 2,000 | $1,050 | 2,000 | +100.0% |
| 2011-12-23 00:48 | 2011-12-21 | Tune Joel A. | Director | BUY | $0.57 | 15,000 | $8,475 | 45,192 | +49.7% |
| 2011-12-23 00:48 | 2011-12-21 | SABATINO THOMAS J JR | Director | BUY | $0.63 | 100,000 | $62,880 | 100,000 | +100.0% |
| 2011-12-23 00:46 | 2011-12-21 | ZVI EIREF | Director | BUY | $0.53 | 10,000 | $5,275 | 187,424 | +5.6% |
| 2011-12-23 00:46 | 2011-12-21 | Mehta Nozer | Officer - VP, Biological R&D | BUY | $0.54 | 1,400 | $749 | 202,895 | +0.7% |
| 2011-12-23 00:46 | 2011-12-21 | Mayes, Gregory T. | Officer - VP, Corp Development and GC | BUY | $0.53 | 2,000 | $1,050 | 2,000 | +100.0% |
| 2010-12-23 02:45 | 2010-12-20 | Levy Richard N | Director | BUY | $0.75 | 150,000 | $112,005 | 9,147,464 | +1.7% |
| 2010-12-22 17:55 | 2010-12-20 | ZVI EIREF | Director | BUY | $0.73 | 15,000 | $10,901 | 140,501 | +12.0% |
| 2010-12-18 02:13 | 2010-12-15 | Levy Richard N | Director | BUY | $0.70 | 101,100 | $70,537 | 8,997,464 | +1.1% |
| 2010-09-21 17:11 | 2010-09-20 | Palmer Ashleigh | Director, Officer - President & CEO | BUY | $0.70 | 8,800 | $6,160 | 50,000 | +21.4% |
| 2010-09-21 17:11 | 2010-09-21 | Steinhauer William Jacob | Officer - Vice President of Finance | BUY | $0.69 | 5,000 | $3,450 | 85,695 | +6.2% |
| 2010-09-08 23:41 | 2010-09-03 | Levy Richard N | Director | BUY | $0.72 | 5,000 | $3,600 | 8,896,364 | +0.1% |
| 2010-09-08 23:12 | 2010-09-03 | SLUSSER PETER | Director | BUY | $0.75 | 2,000 | $1,500 | 59,315 | +3.5% |
| 2010-09-01 00:30 | 2010-08-27 | Levy Richard N | Director | BUY | $0.66 | 245,550 | $162,677 | 8,891,364 | +2.8% |
| 2010-08-19 01:14 | 2010-08-16 | ZVI EIREF | Director | BUY | $0.61 | 21,000 | $12,720 | 125,501 | +20.1% |
| 2010-08-12 23:45 | 2010-08-12 | Palmer Ashleigh | Director, Officer - President & CEO | BUY | $0.60 | 20,000 | $12,000 | 41,200 | +94.3% |
| 2010-06-21 14:21 | 2010-06-18 | Palmer Ashleigh | Director, Officer - President & CEO | BUY | $0.80 | 21,200 | $16,886 | 21,200 | +100.0% |
| 2009-12-03 00:44 | 2009-11-30 | Shields Paul | Officer - Vice Pres. Mfg. Operations | SELL | $0.93 | 67,750 | $63,008 | 0 | -100.0% |
| 2009-11-06 00:44 | 2009-11-03 | GILLIGAN JAMES P | Officer - Vice Pres. of Product Devel. | OPT+S | $1.16 | 75,000 | $87,053 | 118,895 | 0.0% |
| 2008-11-17 16:22 | 2008-11-14 | HENDRICKSON ROBERT F | Director | BUY | $0.59 | 10,000 | $5,900 | 60,000 | +20.0% |
| 2008-11-14 01:36 | 2008-11-13 | SLUSSER PETER | Director | BUY | $0.61 | 1,500 | $915 | 2,000 | +300.0% |
| 2007-05-25 23:10 | 2007-05-23 | GILLIGAN JAMES P | Officer - Vice Pres. of Product Devel. | BUY | $2.40 | 600 | $1,440 | 65,360 | +0.9% |
| 2006-06-13 15:30 | 2006-06-12 | MILLER MARVIN | Director | BUY | $3.46 | 1,000 | $3,460 | 1,000 | +100.0% |
| 2006-03-24 00:46 | 2006-03-21 | Shields Paul | Officer - Vice Pres. Mfg. Operations | OPT+S | $3.75 | 50,000 | $187,400 | 160 | 0.0% |
| 2006-03-24 00:45 | 2006-03-21 | SLUSSER PETER | Director | BUY | $4.00 | 500 | $2,000 | 500 | +100.0% |
| 2006-01-27 02:57 | 2005-12-21 | GILLIGAN JAMES P | Officer - Vice Pres. of Product Devel. | OPT+S | $4.50 | 20,000 | $90,000 | 64,760 | 0.0% |
| 2005-12-24 00:41 | 2005-12-07 | GILLIGAN JAMES P | Officer - Vice Pres. of Product Devel. | OPT+S | $4.05 | 100,000 | $405,200 | 4,600 | 0.0% |
| 2005-12-23 01:12 | 2005-12-21 | Mehta Nozer | Officer - Vice Pres. Biological R&D | OPT+S | $4.43 | 40,000 | $177,292 | 160 | 0.0% |
| 2005-12-22 00:48 | 2005-12-19 | Shields Paul | Officer - Vice Pres. Mfg. Operations | OPT+S | $4.37 | 60,000 | $262,350 | 0 | 0.0% |
| 2005-12-15 00:58 | 2005-12-12 | Mehta Nozer | Officer - Vice Pres. Biological R&D | OPT+S | $4.06 | 10,000 | $40,600 | 0 | 0.0% |
| 2005-12-13 00:34 | 2005-12-09 | Steinhauer William Jacob | Officer - Vice President of Finance | OPT+S | $4.41 | 25,000 | $110,250 | 15,000 | 0.0% |
| 2005-12-13 00:33 | 2005-12-09 | Mehta Nozer | Officer - Vice Pres. Biological R&D | OPT+S | $4.40 | 50,000 | $220,000 | 0 | 0.0% |
| 2005-12-09 00:59 | 2005-12-06 | Shields Paul | Officer - Vice Pres. Mfg. Operations | OPT+S | $3.80 | 100,000 | $380,000 | 0 | 0.0% |
| 2005-12-01 00:34 | 2005-11-28 | GILLIGAN JAMES P | Officer - Vice Pres. of Product Devel. | OPT+S | $3.35 | 20,000 | $67,040 | 19,660 | 0.0% |
| 2004-12-24 00:32 | 2004-12-21 | GILLIGAN JAMES P | Officer - Vice President | OPT+S | $2.19 | 40,000 | $87,600 | 19,660 | 0.0% |
How to Interpret $UGNE Trades
Not every insider transaction in UGNE is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $UGNE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for UGNE
Insider activity data for UGNE is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $UGNE, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.